New preliminary data presented at EHA 2026 highlight the potential of OC-1 in a rare and aggressive blood cancer with limited treatment options.
Read moreCurapath is pleased to acknowledge the significant progress achieved by Macro Biologics, Inc., whose IND application for Amicidin‑α Surgical Gel has been accepted by the FDA, enabling the initiatio...
Read moreEl Biobanco Universidad de Navarra coordina la tramitación de muestras que se recogen en el ensayo clínico para pacientes con tumores cerebrales infantiles iniciado recientemente. Este estudio fase ...
Read moreA paper published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association examines the limitations of current clinical trials in Alzheimer’s disease and proposes ways to better ada...
Read moreUnlike other therapies currently available or under development, INP20 is not designed to desensitise patients to the allergen. Instead, it aims to replicate the biological signals generated by the gu...
Read moreUn ensayo clínico con participación de la URV evalúa si incorporar actividades sociales, lúdicas y musicales a la rehabilitación mejora la recuperación funcional, cognitiva y emocional de los pa...
Read moreA Phase I clinical trial shows that the oncolytic virus VCN-01 can transform the tumor microenvironment and enhance the effect of immunotherapy in patients with poor prognosis.
Read moreAs the clinical research industry continues to grow, companies are facing increasing pressure to meet strict regulatory requirements while keeping studies moving efficiently. Sponsors today need depen...
Read moreIt has been revealed that the use of HyperSperm technology, developed by this Barcelona-based company, increases not only the number of viable embryos but also their quality.
Read more